Access Bio (950130.KQ) Earnings Analysis
Access Bio (950130.KQ) has no confirmed upcoming earnings date. Trailing P/E -13.07.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 950130.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 950130.KQ. This page updates as the calendar is published.
950130.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-12-31 | 2.83 KRW | n/a | n/a | n/a |
| 2024-09-30 | -135 KRW | n/a | n/a | n/a |
950130.KQ valuation and analyst view
| Trailing P/E | -13.07 |
|---|---|
| Trailing EPS | -487.13484 KRW |
| Price / book | 0.38 |
| Dividend yield | 0.00% |
| Market cap | 78.79B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Access Bio (950130.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 950130.KQ. This page updates as the calendar is published.
Did 950130.KQ beat earnings last quarter?
Consensus estimate data was not available for 950130.KQ's 2024-12-31 report.
What is 950130.KQ's current P/E ratio and EPS?
950130.KQ trades at a trailing P/E of -13.07 on trailing EPS of -487.1348413714611 KRW.
What do analysts rate 950130.KQ?
950130.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.